Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 137

1.

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study.

Murray DD, Suzuki K, Law M, Trebicka J, Neuhaus J, Wentworth D, Johnson M, Vjecha MJ, Kelleher AD, Emery S; INSIGHT ESPRIT and SMART Study Groups..

PLoS One. 2015 Oct 14;10(10):e0139981. doi: 10.1371/journal.pone.0139981. eCollection 2015.

2.

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration..

Lancet HIV. 2015 Aug;2(8):e335-43. doi: 10.1016/S2352-3018(15)00108-3. Epub 2015 Jul 7.

3.

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group.; Royal Free Hospital Clinic Cohort.; INSIGHT study group.; SMART study group.; ESPRIT study group..

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.

4.

A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals.

Moyle GJ, Orkin C, Fisher M, Dhar J, Anderson J, Wilkins E, Ewan J, Ebrahimi R, Wang H; ROCKET 1 (Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial) Study Group..

PLoS One. 2015 Feb 6;10(2):e0116297. doi: 10.1371/journal.pone.0116297. eCollection 2015.

5.

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups.; SILCAAT Scientific Committee..

J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844.

6.

Factors associated with D-dimer levels in HIV-infected individuals.

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD; INSIGHT SMART Study Group.; ESPRIT Study Group.; SILCAAT Scientific Committee..

PLoS One. 2014 Mar 13;9(3):e90978. doi: 10.1371/journal.pone.0090978. eCollection 2014.

7.

Glue ear, hearing loss and IQ: an association moderated by the child's home environment.

Hall AJ, Maw R, Midgley E, Golding J, Steer C.

PLoS One. 2014 Feb 3;9(2):e87021. doi: 10.1371/journal.pone.0087021. eCollection 2014.

8.

Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.

Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM; INSIGHT SMART Study Group..

PLoS One. 2013;8(2):e56249. doi: 10.1371/journal.pone.0056249. Epub 2013 Feb 15.

9.

The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.

Cain LE, Phillips A, Lodi S, Sabin C, Bansi L, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, de Wolf F, Bucher HC, Elzi L, Touloumi G, Vourli G, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Abgrall S, Costagliola D, Hernán MA; HIV-CAUSAL Collaboration..

AIDS. 2012 Aug 24;26(13):1691-705.

10.

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, Pérez-Hoyos S, Jarrín I, Phillips A, Lodi S, van Sighem A, de Wolf W, Sabin C, Bansi L, Justice A, Goulet J, Miró JM, Ferrer E, Meyer L, Seng R, Toulomi G, Gargalianos P, Costagliola D, Abgrall S, Hernán MA; HIV-CAUSAL Collaboration..

Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28.

11.

Assessing the understanding and prior uptake of human papillomavirus vaccination among eligible females attending genitourinary medicine clinics in UK.

McCarty EJ, O'Mahony C, Bates S, Fox P, Maw RD.

Sex Transm Infect. 2011 Oct;87(6):488. doi: 10.1136/sextrans-2011-050142. No abstract available.

PMID:
21917696
12.

Survey of the management of patients with genital dermatological problems in genitourinary/sexual health clinics in the UK.

Sashidharan PN, Goorney B, Cassell J, Edwards S, Maw R, Kell P.

Sex Transm Infect. 2011 Aug;87(5):414. doi: 10.1136/sextrans-2011-050152. No abstract available.

PMID:
21772043
13.

Post-exposure prophylaxis following sexual exposure to HIV: a seven-year retrospective analysis in a regional centre.

McCarty EJ, Quah S, Maw R, Dinsmore WW, Emerson CR.

Int J STD AIDS. 2011 Jul;22(7):407-8. doi: 10.1258/ijsa.2009.009463.

PMID:
21729962
14.

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

HIV-CAUSAL Collaboration., Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, Justice A, Goulet J, van Sighem A, de Wolf F, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Perez-Hoyos S, Muga R, Lodi S, Lanoy E, Costagliola D, Hernan MA.

Ann Intern Med. 2011 Apr 19;154(8):509-15. doi: 10.7326/0003-4819-154-8-201104190-00001.

15.

Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz.

Cooper V, Moyle GJ, Fisher M, Reilly G, Ewan J, Liu HC, Horne R; SWEET (Simplification With Easier Emtricitabine Tenofovir) group, UK..

AIDS Care. 2011 Jun;23(6):705-13. doi: 10.1080/09540121.2010.534433.

PMID:
21476152
16.

A survey of sexual health services in UK prisons.

Tang A, Maw R, Kell P; British Cooperative Clinical Group..

Int J STD AIDS. 2010 Sep;21(9):638-41. doi: 10.1258/ijsa.2010.010177.

PMID:
21097737
17.

National audit of asymptomatic screening in UK genitourinary medicine clinics: clinic policies audit.

Carne CA, McClean H, Sullivan AK, Menon-Johansson A, Gokhale R, Sethi G, Mammen-Tobin AG, Daniels D; National Audit Group of the British Association for Sexual Health and HIV..

Int J STD AIDS. 2010 Jul;21(7):512-5. doi: 10.1258/ijsa.2010.009573.

PMID:
20852203
18.

National audit of asymptomatic screening in UK genitourinary medicine clinics: case-notes audit.

McClean H, Carne CA, Sullivan AK, Menon-Johansson A, Gokhale R, Sethi G, Mammen-Tobin AG, Daniels D; National Audit Group of the British Association for Sexual Health and HIV..

Int J STD AIDS. 2010 Jul;21(7):506-11. doi: 10.1258/ijsa.2010.009572.

PMID:
20852202
19.

Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).

Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S; INSIGHT-ESPRIT Study Group..

HIV Med. 2011 Apr;12(4):219-27. doi: 10.1111/j.1468-1293.2010.00875.x. Epub 2010 Aug 31.

20.

Availability of services for subjects of sexual assault in genitourinary medicine clinics.

Mandal D, Maw RD, Carne CA, Opaneye A, Thirunavukarasu T; British Co-operative Clinical Group of the British Association for Sexual Health and HIV (BASHH)..

Int J STD AIDS. 2010 May;21(5):317-9. doi: 10.1258/ijsa.2009.009540.

PMID:
20498098

Supplemental Content

Loading ...
Support Center